InsidersTradesSigma
Track the SenzaGen AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, SenzaGen AB has published 2 reports. Market capitalisation: €173.6m. The latest transaction was filed on 21 August 2025 (Purchase). Among the most active insiders: Bengt Peter Nählstedt. Every trade is openly available.
2
Insider Decl.
n/a
Thresholds
€22,060
2 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Fundamental score
Ranked 24,499 of 29,064 companies
27.3
score / 100
Value19
Quality36
FCF yld-7.1%
Earn yld-6.7%
EV/EBITDA·
ROE-13%
Gross mgn65%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2025
Declarations2 total
250,000 shares@ €0.06790.0097% mcap100.0% of flowTeckningsoptionFI:A003R608-1
10,000 shares@ €0.50770.0029% mcap100.0% of flowAktieISIN SE0010219626FI:A003P059-1
2 of 2 declarations
Acerca de SenzaGen AB
SenzaGen AB es una empresa enfocada en el desarrollo de pruebas de seguridad para productos químicos y farmacéuticos. Se especializa en soluciones innovadoras para evaluar los efectos de las sustancias en la salud humana.